Phase I clinical trials testing the efficacy and safety of mesenchymal stem cells in chronic kidney disease treatment include trials using autologous bone marrow MSCs (NCT02166489 and NCT02195323) and adipose-derived MSCs (NCT02266394 and NCT01840540).

Authors

• Person: Not available Organization: Nature
  Cellular rejuvenation: molecular mechanisms and potential ... - Nature

Sources

• Cellular rejuvenation: molecular mechanisms and potential ... - Nature www.nature.com Nature via serper

Referenced by nodes (2)

• chronic kidney disease concept
• mesenchymal stromal cells concept